- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
May 7th, 2007
NanoViricides Inc. saw its stock jump 8 percent Monday after the company announced positive results of recent tests of its antiviral drug designed to treat bird flu.
The stock, which trades on the Pink Sheets market as NNVC.pk, rose 9 cents to close at $1.19 a share Monday.
NanoViricides, based at 135 Wood St., recently carried out in vitro testing of its FluCide-HP — an antiviral drug delivered by nanotechnology — in Vietnam.
|Related News Press|
PEN Inc. Announces 1-for-180 Reverse Stock Split January 27th, 2016
Nanoparticle therapy that uses LDL and fish oil kills liver cancer cells February 9th, 2016
Leading bugs to the death chamber: A kinder face of cholesterol February 8th, 2016
UTHealth research looks at nanotechnology to help prevent preterm birth February 7th, 2016
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
Scientists take nanoparticle snapshots February 10th, 2016
Chemical cages: New technique advances synthetic biology February 10th, 2016
Omni Nano and Time Warner Cable Partner to Provide Nanotechnology Education to the Boys & Girls Clubs of Los Angeles: A $10,000 Donation to Benefit Youth of Los Angeles County's Boys & Girls Clubs August 4th, 2015
Kalam: versatility personified August 1st, 2015